HLA-E Antikörper (AA 251-358)
(2 Referenzen)Kurzübersicht für HLA-E Antikörper (AA 251-358) (ABIN674334)
Target
Alle HLA-E Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 251-358
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human HLA E
-
Isotyp
- IgG
-
-
anti-HLA Class I Histocompatibility Antigen, alpha Chain E (HLA-E) antibody
HLA-E Reaktivität: Human, Non-Human Primate FACS, IP, IHC (p) Wirt: Maus Monoclonal MEM-E-06 unconjugated
anti-HLA Class I Histocompatibility Antigen, alpha Chain E (HLA-E) (AA 1-358) antibodyHLA-E Reaktivität: Human WB, FACS Wirt: Maus Polyclonal unconjugated
anti-HLA Class I Histocompatibility Antigen, alpha Chain E (HLA-E) (AA 22-358) antibodyHLA-E Reaktivität: Human WB, IP, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-HLA Class I Histocompatibility Antigen, alpha Chain E (HLA-E) antibody (Biotin)HLA-E Reaktivität: Human FACS, IP, IHC (p) Wirt: Maus Monoclonal MEM-E-07 Biotin
anti-HLA Class I Histocompatibility Antigen, alpha Chain E (HLA-E) antibodyHLA-E Reaktivität: Human FACS, ELISA, IP Wirt: Maus Monoclonal 3D12 unconjugated
anti-HLA Class I Histocompatibility Antigen, alpha Chain E (HLA-E) (AA 108-135) antibodyHLA-E Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB22054 unconjugated
anti-HLA Class I Histocompatibility Antigen, alpha Chain E (HLA-E) (AA 1-100) antibodyHLA-E Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-HLA Class I Histocompatibility Antigen, alpha Chain E (HLA-E) antibody (PE)HLA-E Reaktivität: Human FACS Wirt: Maus Monoclonal 3D12 PE
anti-HLA Class I Histocompatibility Antigen, alpha Chain E (HLA-E) antibody (APC)HLA-E Reaktivität: Human FACS Wirt: Maus Monoclonal 3D12 APC
anti-HLA Class I Histocompatibility Antigen, alpha Chain E (HLA-E) antibodyHLA-E Reaktivität: Human, Primate WB, IHC, IHC (p) Wirt: Maus Monoclonal MEM-E-02 unconjugated
-
-
Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
FCM 1:20-100
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
-
: "High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer." in: Oncoimmunology, Vol. 6, Issue 1, pp. e1264562, (2017) (PubMed).
-
: "High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer." in: Oncoimmunology, Vol. 6, Issue 1, pp. e1264562, (2017) (PubMed).
-
- HLA-E (HLA Class I Histocompatibility Antigen, alpha Chain E (HLA-E))
-
Andere Bezeichnung
- HLA E
-
Hintergrund
-
Synonyms: MHC, QA1, EA1.2, EA2.1, HLA-6.2, HLA class I histocompatibility antigen, alpha chain E, MHC class I antigen E, HLA-E, HLAE
Background: HLA E belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. HLA E binds a restricted subset of peptides derived from the leader peptides of other class I molecules.
-
Gen-ID
- 3133
-
UniProt
- P13747
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-
